Saturday, February 7, 2015

Avoid Coca-Cola, Buy Monster or Dr Pepper for More Satisfying Profit

Stocks in this article: DPS KO GMCR MNST PBJ PEP SPX

NEW YORK (TheStreet) -- Global beverage giant Coca-Cola (KO - Get Report) will report fourth-quarter and full-year results Tuesday before the opening bell. With just 2% stock gains in 2014 compared with 14% gains for rival PepsiCo (PEP - Get Report) , Coca-Cola shareholders must be wondering why they hang around.
Coca-Cola shares are down 1.37% for the year to date, trailing the broader averages, which have traded flat. By contrast PepsiCo shares are up 2.5%. But this is no taste test. Coke is going flat and needs something to put the fizz back.

In the meantime, there are other places for your investment dollars, specifically two companies in which Coke has bought major stakes -- Monster Beverage (MNST) and Keurig Green Mountain Coffee (GMCR) .
Those moves have paid off. Keurig Green Mountain shares soared in 2014 more than 82%, while Monster stock has added more than 60% gains. Unfortunately, beyond Coca-Cola's quarterly dividend yield of 2.93%, investors didn't see any of those gains. While Coca-Cola stock is languishing in negative territory in 2015, Monster Beverage shares are up 8% for the year to date, beating the broader averages.
So it makes more sense for Coca-Cola investors to buy shares in Monster.
Besides, Coca-Cola shares are not cheap. They trade at 23 times trailing earnings, which is three points higher than the average price to earnings ratio of companies in the S&P 500 (SPX) . it is also three points higher than PowerShares Dynamic Food & Beverage Portfolio (PBJ) , which includes PepsiCo, Monster Beverage and Dr Pepper Snapple (DPS) .

Dr. Pepper Snapple's shares are up nearly 9% for the year to date with a P/E ratio almost two points lower than Coca-Cola. Coke's higher P/E implies Wall Street still expects the company to turn things around and outgrow its peers -- something it hasn't been able to do in almost two years.
For the quarter ending in December, Coke is expected to report 42 cents per share in earnings on revenue of $10.76 billion, representing year-over-year declines of 8% and 2.5%, respectively. For the full-year, earnings are projected to decline 2% year over year to $2.03 per share, while revenue is expected to be $45.9 billion, down 2% year over year.

No comments:

Post a Comment